UniQure gene therapy shows promising result in mid-stage trial
Gene therapy company UniQure NV said on Friday its treatment for hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a relatively small study. (Source: Reuters: Health)
Source: Reuters: Health - February 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

UniQure gene therapy shows rise in blood-clotting protein levels
Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a small study. (Source: Reuters: Health)
Source: Reuters: Health - February 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

UniQure gene therapy shows rise in blood-clotting protein in trial
UniQure NV said on Friday its gene therapy to treat patients with a blood disorder, hemophilia B, increased the levels of a protein that helps in blood clotting after 12 weeks. (Source: Reuters: Health)
Source: Reuters: Health - February 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Roche, Joining Rivals, Donates Hemophilia Drug to Boost Access Roche, Joining Rivals, Donates Hemophilia Drug to Boost Access
Switzerland ' s Roche will donate its new hemophilia A drug Hemlibra to a World Hemophilia Federation program, it said on Wednesday, joining rivals who also back the effort to help patients in developing countries who face treatment hurdles.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Takeda ordered to shell out $155m to Bayer for patent infringement
Jurors in a U.S. federal court have ordered a Takeda Pharmaceutical Co. unit to pay Bayer AG $155.19 million for a case related to a hemophilia drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 7, 2019 Category: Pharmaceuticals Source Type: news